Day: March 1, 2022

EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, announced today its Chairman and Chief Executive Officer, Jim Neal, will be featured in a fireside chat at the 42nd Annual Cowen Health Care Conference on Monday, March 7, 2022, at 1:30 PM ET. The presentation can be accessed at https://bit.ly/3rPGmLl or by visiting the investor relations section of the Company’s website at www.xoma.com.  A replay of the presentation will be available and archived on the site for 90 days after the event. About XOMA CorporationXOMA is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.  XOMA acquires...

WASHINGTON, March 01, 2022 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Melissa Wichman as a Senior Managing Director in the Transactions practice, where she will lead the Transactions Tax offering. Ms. Wichman, who is based in Chicago, brings 30 years of experience advising both private equity and strategic buyers on tax due diligence and structuring acquisitions and divestitures. She has extensive experience ranging from mid-market transactions to large private equity-backed deals. Her appointment enhances FTI Consulting’s capabilities to provide end-to-end support to clients throughout the deal lifecycle. “Our clients are continually asking for broader tax solutions, as the complexity of their transactions continues to increase,” said Scott Bingham, Leader of the U.S. Transactions practice...

Company rapidly prepares to submit IND and Breakthrough Therapy Status Applications DENVER, March 01, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced a positive meeting with the Food and Drug Administration (FDA) regarding their Investigational New Drug (IND) and breakthrough therapy status applications. The Company reported a meeting with the FDA on February 28th to review their IND application to administer MYCO-001, in combination with therapy, to humans as part of smoking cessation treatment. Leading drug and substance abuse researcher, Dr. Matthew Johnson of Johns Hopkins University, will serve as the lead investigator for this multi-site...

LAS VEGAS, NV, March 01, 2022 (GLOBE NEWSWIRE) — WarpSpeed Taxi Inc. (OTC Pink: WRPT) (“WarpSpeed” or the “Company”), the developer of an all-in-one software solution for ride hailing, food delivery, and courier services, is excited to update current and prospective shareholders with more details about the Company’s unique business plan to disrupt the global Ride Hailing & Delivery Space over the coming five years. For more information including the detail Business Plan, please visit https://warpspeedtaxi.com/landing/ Daniel Okelo, CEO of WarpSpeed Taxi, stated, “We have invested ourselves in the development of a unique model built from the ground up to drive rapid, cost-effective penetration in every geographic market around the world. Our shares just started trading, and we believe they represent a ground floor opportunity...

Dennis Curran, former GSK & P&G Executive, named COO of Acreage NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U), (OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., today announced the appointment of Dennis Curran as the Company’s Chief Operating Officer (“COO”). The Company also announced the resignation of James Doherty, General Counsel, effective April 30, 2022, and has launched a national search for his successor. “Over the last year, we have made significant strides to strengthen our management team, and today we further these efforts with the addition of Dennis as our new COO,” said Peter Caldini, CEO of Acreage Holdings. “Dennis has a distinguished track record...

BRISBANE, Calif., March 01, 2022 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that Marshall Fordyce, MD, founder and CEO, will present and participate in one-on-one investor meetings at the 42nd Annual Cowen Health Care Conference taking place March 7-9, 2022.Presentation Details:   Format: Corporate Panel DiscussionDate: Wednesday, March 9thTime: 2:10-3:10 PM ETWebcast: A live audio webcast is available by choosing the following link https://wsw.com/webcast/cowen108/panel28/2332386 A replay of the event will be available for 30 days and can be accessed by visiting the “Investor Calendar” section of the Vera Therapeutics website. About...

VANCOUVER, British Columbia, March 01, 2022 (GLOBE NEWSWIRE) — Mexican Gold Mining Corp. (the “Company” or “Mexican Gold”) (TSXV: MEX, OTCQB: MEXGF) is pleased to announce the appointment of Julie Van Baarsen as Chief Financial Officer of the Company effective today’s date. Julie van Baarsen is an effective leader and accounting professional with significant experience in public company reporting, IFRS, internal controls and auditing. She brings 30 years of experience across diverse financial leadership positions having previously served as Chief Financial Officer of companies listed on both the TSX Venture Exchange and Toronto Stock Exchange. She has also held a variety of public accounting practice positions, including audit manager of Grant Thornton LLP, and completed numerous consulting engagements focused on financial...